Home » US Lawmakers Want to Give FDA Broader Powers for Foreign Activities
US Lawmakers Want to Give FDA Broader Powers for Foreign Activities
October 14, 2010
Given increasing concerns with the quality and integrity of drug products manufactured overseas, a group of U.S. congressmen is floating a draft of a bill that would give the U.S. Food and Drug Administration (FDA) broader powers and bring the agency’s inspections of foreign plants in line with U.S.-based ones.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor